Decreased matrix metalloproteinase activity in the kidneys of hereditary nephrotic mice (ICGN strain)

Nephron

Volumn 86, Issue 2, 2000, Pages 145-151

  Uchio, Kozue ^a   Manabe, Noboru ^a   Tamura, Kotaro ^a   Miyamoto, Makoto ^a   Yamaguchi, Misuzu ^a   Ogura, Atsuo ^b   Yamamoto, Yoshie ^b   Miyamoto, Hajime ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Extracellular matrix; Glomerulonephritis; Hereditary nephrotic mouse (ICGN); Matrix metalloproteinase

Indexed keywords

COLLAGEN TYPE 1; MATRIX METALLOPROTEINASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENETIC DISORDER; GLOMERULONEPHRITIS; HISTOPATHOLOGY; MOUSE; NEPHROTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL;

EID: 0033819775     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045733     Document Type: Article

References (23)

1. Ogura A, Asano T, Matsuda J, Noguchi Y, Yamamoto Y. Takano K, Nakagawa M: Development of nephrotic ICGN mice: The origin, reproductive ability, and incidence of glomerulonephritis. Exp Anim 1989;38:349-352.
2. Ogura A, Asano T, Matsuda J, Takano K, Nakagawa M. Fukui M: Characteristics of mutant mice (ICGN) with spontaneous renal lesion: A new model for human nephrotic syndrome. Lab Anim 1989;23:169-174.
3. Ogura A, Asano T, Fujimura H: Animal model of human disease: Inherited nephrotic syndrome. Comp Pathol Bull 1994;26:3-6.
4. Ogura A, Asano T, Suzuki O, Yamamoto Y, Noguchi Y, Kawaguchi H, Yamaguchi Y: Hereditary nephrotic syndrome with progression to renal failure in a mouse model (ICGN strain): Clinical study. Nephron 1994;68:239-244.
5. Ogura A, Asano T, Matsuda J, Fujimura H: Evolution of glomerular lesions in nephrotic ICGN mice: Serial biopsy study wtih electron microscopy. J Vet Med Sci 1991;53:513-515.
6. Ogura A, Asano T, Matsuda J, Koura M, Nakagawa M, Kawaguchi H, Yamaguchi Y; An electron microscopic study of glomerular lesions in hereditary nephrotic mice (ICGN strain). Virchows Arch A Pathol Anal Histopathol 1990; 417:223-228.
7. Ogura A, Fujimura H, Asano T, Koura M, Naito I, Kobayashi Y: Early ultrastructural glomerular alteration in neonatal nephrotic mice (ICGN strain). Vet Pathol 1995;32:321-323.
8. Tatsumi H, Satoh S, Okamoto M, Nakamura M, Asano T, Kurosawa T: Morphological studies on the kidney of the spontaneous nephrotic (ICGN) mice in the late stage. Acta Anat Nippon 1995;70:96-106.
9. Mizuno S, Yue BF, Okamoto M, Horikawa Y, Kurosawa T: Diffuse glomerulosclerosis without tubular injury does not directly manifest renal dysfunction in nephrotic mice (ICGN strain). Exp Nephrol 1997;5:498-507.
10. Uchio K, Manabe N, Kinoshita A, Tamura K, Miyamoto M, Ogura A, Yamamoto Y, Miyamoto H: Abnormalities of extracellular matrices and transforming growth factor βI localization in the kidney of the hereditary nephrotic mice (ICGN strain). J Vet Vied Sci 1999;61: 769-776.
11. Suzuki D: Metalloproteinases in the pathogenesis of diabetic nephropathy. Nephron 1998; 80:125-133.
12. Davis M, Martin J, Thomas GJ, Lovett DH: Proteinases and glomerular matrix turnover. Kidney Int 1992;41:671-678.
13. McMillan JI, Rioedan JW, Couser WG, Pollock AS, Lovett DH: Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression on a model of membranous nephropathy. J Clin Invest 1996;97:1094-1101.
14. Werb Z: ECM and cell surface proteolysis: Regulating cellular ecology. Cell 1997;91:439-442.
15. Tamura K, Manabe N, Uchio K, Miyamoto M, Ogura A, Yamamoto Y, Nagano N, Furuya Y, Miyamoto H: Characteristic changes in carbohydrate profile in the kidneys of hereditary nephrotic mice (ICGN strain). J Vet Med Sci, in press.
16. Manabe N, Furuya Y, Nagano N, Yagi M, Kuramitsu K, Miyamoto H: Immunohistochemical quantitation for extracellular matrix proteins in rats with glomerulonephritis. Nephron 1995;71:79-86.
17. Mizuno S, Mizuno-Horikawa Y, Yue-Bing F, Okamoto M, Kurosawa T; Nephrotic mice (ICGN strain): A model of diffuse mesangial sclerosis in infantile nephrotic syndrome. Am J Nephrol 1999;19:73-82.
18. Mizuno S, Horikawa Y, Okamoto M, Kurosawa T: Preventive effect of ACE inhibitor on interstitial myofibroblast formation and matrix deposition in a nephrotic model. Ren Fail 1998;20:481-491.
19. Mizuno S, Kurosawa T, Matsumoto K, Mizuno-Horikawa Y, Okamoto M, Nakamura T: Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest 1998;101: 1827-1834.
20. Sütö TS, Fine LG, Shimizu F, Kitamura M: In vivo transfer of engineered macrophage into the glomerulus. J Immunol 1997;159:2476-2483.
21. Kitamura M: TGF-β1 as an endogenous defender against macrophage-triggered stromelysin gene expression in the glomerulus. J Immunol 1998;160:5163-5168.
22. Baricos WH, Cortez SL, Deboisblane M, Xin S: Transforminggrowth factor-β is a potent inhibitor of extracellular matrix degradation by cultured human mesangial cells. J Am Soc Nephrol 1999;10:790-795.
23. Lenz O, Striker LJ, Jacot TA, Elliot SJ, Killen PD, Striker GE: Glomerular endothelial cells synthesize collagens but little gelatinase A and B. J Am Soc Nephrol 1998;9:2040-2047.